Anthem Taps Artificial Intelligence Space With Allergy Research Trial
Anthem is partnering with artificial intelligence platform doc.ai in a research trial to examine whether the technology works to predict when people will experience allergies.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NYSE:UNH NYSE:ANTM Source Type: news